Navegando por Assunto "Diabetes Mellitus"

Agora exibindo 1 - 13 de 13

A influência da metformina no declínio neurocognitivo: uma revisão sistemática com metanálise
(Centro Universitário do Estado do Pará, 2021) Nakanishi, Deborah Ayumi Alves; Aragão, Diego Armando Barbosa; Teixeira, Cláudio Eduardo Corrêa; http://lattes.cnpq.br/7448998858430931
Background: Blood glucose variations are generally associated with predisposition to the development of dementia in diabetes patients. And there is a controversy in the literature about whether the use of antihyperglycemic agents can(not) promote protective effects on cognition. Design and setting: we used a systematic review with meta-analysis to evaluate whether the evidence in the literature points to a protective or harmful effect of antihyperglycemic agents on cognition. Methods: PubMed, Science Direct and Scielo databases were used to collect articles in English, published between 2005 and 2020. Articles of reflection/opinion, monographs/theses/dissertations, and animal research were excluded. The blinding of authors during the searches contributed to search independence. Of 1,329 articles selected, 30 were adequate, but only 3 of these provided quantitative data from 53 cognitive tests, which were used for meta-analysis (random effect model), performed using R. Results: Funnel plot shows no publication bias. Forest plot, on the other hand, shows that literature points to the use of antihyperglycemic agents by patients as preventive of cognitive losses (standard mean difference equal to -0.18 [95% confidence interval between -0.29 and -0.06]). Conclusion: Evidence of the preventive effect of cognitive losses through the use of antihyperglycemic agents such as metformin should be further investigated, in order to better clarify this therapeutic potential.
Alterações auditivas no Diabetes Mellitus
(Centro Universitário do Estado do Pará, 2019) Lima, Arthur Felipe Maciel de; Hamamura, Rubens Yuji; Rocha, Vanessa Campos Couto da; Nunes, Leonardo Mendes Acatauassú; http://lattes.cnpq.br/3512764081076675; http://lattes.cnpq.br/1897095774561517
Diabetes Mellitus is a chronic condition with a potential to injure several organs, such as the eyes, kidneys, heart, blood vessels, nerves, and brain. Therefore, it is possible that these anatomopathological changes due to hyperglycemia may also alter the organs responsible for hearing. This work was carried out to investigate and establish a correlation between Diabetes Mellitus and reduction of auditory acuity, based on the investigation of the hearing threshold and cochlear function of the patients included in the study. This is an observational, analytical, case-control study in which the patients were selected through a chart analysis of the Endocrinology service of the CESUPA Medical Specialties Center. The sample consisted of (10) patients with diabetes mellitus and (10) patients in the control group, regardless of sex, between 18 and 70 years of age, and the study was performed from October 2018 to January 2019. In the present study it was verified that 100% of the hearing losses were of bilateral sensorineural character, with predominance in females aged between 60-70 years, in the case group. Diabetes mellitus type 2 was predominant, corresponding to 90% of the sample in the case group. 60% of the patients observed had DM for more than 10 years; The most prevalent hearing loss was observed in the frequencies of 6 and 8 kHz (70% in both frequencies). The results of the Distortion-Product Otoacoustic Emissions (DPOAEs) exam showed that 10% of the patients in the case group had absent emissions in the left ear and 20% had the same result in the right ear. Among the members of the control group, the percentage of patients with absence of emissions for both the left and right ears is 20%. These results suggest that hearing loss may be related to the metabolic, neurological and circulatory repercussions of Diabetes Mellitus. This fact underscores the importance of the development of researches both for the early diagnosis of Diabetes and for a more solid investigation of the impact on the hearing of patients with the disease.
Análise dos fatores de risco para o desenvolvimento de fragilidade óssea em pacientes portadores de diabetes mellitus tipo 2 atendidos no Centro de Especialidades Médicas do CESUPA
(Centro Universitário do Estado do Pará, 2022) Oliveira, Ana Clara Moura de; Medeiros, Luma de Melo; Lima, Glauce Leão; Araújo, Fernando Costa; http://lattes.cnpq.br/6048529625820449; http://lattes.cnpq.br/7526159894502830
INTRODUCTION: Diabetes mellitus (DM) is a chronic metabolic disease with high worldwide prevalence. Type 2 diabetes patients are at risk of developing several complications, with bone fragility being the most recently reported. Osteoporosis is characterized by low bone mass, which predisposes to fragility fractures, being the gold standard method for its diagnosis the bone densitometry exam. The influence of diabetes on bone has multifactorial etiology, requiring further studies to make this relationship more consistent. OBJECTIVES: To analyze the presence of risk factors associated with the development of bone fragility and osteoporosis in type 2 diabetic patients treated at the “Centro de Especialidades Médicas do CESUPA” (CEMEC), and also generate an educational product with the purpose of guidance and health promotion, for use in the specialty medical clinics. METHODOLOGY: A cross- sectional, observational and analytical-descriptive study was carried out, based on an interview with the application of a specific questionnaire to patients treated at the “Centro de Especialidades Médicas do Cesupa” (CEMEC), and also an analysis of laboratorial and image exams that were contained in the medical records. RESULTS: A sample of 80 patients was used, being 72,5% female and aged between 51-70 years (58,8%). Most (52,5%) had been diagnosed with diabetes for more than 10 years, 70% had fasting glucose <150mg/dL and 77,5% had glycated hemoglobin levels below 8,5%. Among the 80 patients surveyed, 48,8% referred to be a former smoker in the past and 16,3% reported chronic use of corticosteroids. Most (66,3%) related using antidiabetic drugs with an impact on bone metabolism, 8,8% reported previous fragility bone fractures and 26,4% of the fifty-three patients with target-organ lesions had diabetic neuropathy. Those who underwent bone densitometry corresponded to 42,5%, of whom 28,8% received the densitometric diagnosis of osteoporosis. Most (46,3%) individuals had an average fracture risk calculated by FRAX®. CONCLUSION: There was a significant association between previous fragility fracture, smoking and chronic use of corticosteroids with increased risk of fracture. Bone fragility should be considered a complication of diabetes, and the design of prevention and screening strategies is essential, in addition to spreading information to patients about their disease and ways to improve its control.
Avaliação da acurácia diagnóstica entre glicemia capilar e glicemia venosa no diagnóstico de hiperglicemia hospitalar
(Centro Universitário do Estado do Pará, 2021) Abreu, Júlio César Setubal Modesto de; Medeiros, Rogério Corrêa; Moraes Junior, Rudival Faial de; http://lattes.cnpq.br/5666162407518627
Hospital hyperglycemia is a very common clinical condition, including in patients requiring hospitalization, with stress hyperglycemia as one of the factors. This condition has negative repercussions for the patient, such as increased mortality rate and risk of cardiovascular events. The study was developed in the Fundação Santa Casa de Misericórdia do Pará - FSCMPA, in the medical clinic wards of the hospital, São Roque and São Paulo, and the glycemic values were collected in two ways, one by venipuncture and the other by capillary blood sampling. The venous puncture used a colorimetric method, with internal quality controls Level 1 and 2; the capillary glucose determination used electrochemical reactive strips (glucose dehydrogenase) by glucometer, using Level 1 and 2 control solutions. For the analysis of numeric variables, the Shapiro Wilk Normality test was used, so in case of normality the One Criterion ANOVA test will be calculated and in case of non-normality the Krulkal Wallis test. Categorical variables were evaluated using the Chi-square Adherence Tests for univariate tables and G and Chi-square Independence Tests for bivariate tables. BioEstat® 5.3 software was used for descriptive and analytical analyses, using the significance level α=0,05 or 5%. It was observed that 93.3% of patients had glycemic concentration higher than 140 mg/dL when performed via capillary blood glucose, while 90% had concentration higher than 140 mg/dL when performed venous blood glucose measurement. The capillary blood glucose was generally higher (140 to 450 mg/dL) compared to the venous blood glucose (118 to 394 mg/dL). However, the median variation between methods (9.8%) is within the confidence interval for the median variation, demonstrating that the values are within those recommended by the FDA, the ADA, and the ISO. As the result, capillary blood glucose can be safely used, as it is as accurate as venous blood glucose for the diagnosis of hospital-acquired hyperglycemia.
Avaliação do impacto da utilização do sistema de infusão contínua de insulina na qualidade de vida de pacientes portadores de Diabetes Mellitus do tipo 1
(Centro Universitário do Estado do Pará, 2023-05-30) Monteiro, Demmy Chaves Amaral; Chaves, Michelle Luiza da Silva; Santos, Flávia Marques; http://lattes.cnpq.br/8601394323526613; Rocha, Mônica Souza Filho Moura; http://lattes.cnpq.br/1302412321438738; Miranda, Nádia Costa de; http://lattes.cnpq.br/6968956833621813
Type 1 Diabetes Mellitus (DM1) is a chronic autoimmune disease with a genetic determinant in which there is an absence or deficiency in the production of insulin, which regulates blood glucose and provides energy for the body. People with this disease are permanently dependent on exogenous insulin for homeostasis of glucose metabolism. The treatment to replenish insulin stocks is usually uncomfortable, presenting certain limitations to daily life. One way to minimize the negative impact of therapy and improve quality of life (QoL) is through the continuous insulin infusion system. To evaluate the quality of life with the use of the Continuous Insulin Infusion System in patients with Type 1 Diabetes Mellitus in the DM1 outpatient clinic of the Medical Specialties Center of CESUPA. Cross-sectional study that evaluates, through a modified questionnaire, the quality of life of 8 patients of both sexes, with DM1, in use of SICI for at least 6 months, accompanied at the Medical Specialties Center of CESUPA (CEMEC). Satisfaction with treatment assessed by part I of the questionnaire is high, with a value of 75% very satisfied and 25% satisfied. Of the analyzed subscales, “Impact on Social Life" is the one that presents the least satisfaction (62.5%) and “Well-being” is the one that presents the greatest satisfaction (100%). “decrease in the number of punctures” (37.5%) and “better glycemic control” (25%). In points of displeasure, “nothing” is reported in 37.5% of patients. 62.5% of patients had a total of 0 episodes of severe hypoglycemia in the last year, and 50% had an average decrease of 0.6-1 in HbA1c from the first year of pump placement compared to the year of the survey. Regarding quality of life, 75% of the patients obtained “Excellent” and 25% “Good” QoL, with a result of 120.6 ‡14.4. This study reveals a high QoL index for this sample of patients, ranging from “good” to “excellent”. The joint analysis of satisfaction with treatment and clinical data revealed that not only do patients have a positive perception of treatment in different areas of life, but also the positivity is proven by clinical data.
Desenvolvimento de uma tecnologia educativa sobre contagem de carboidratos para pessoas com Diabetes Mellitus
(Centro Universitário do Estado do Pará, 2022) Souza, Maysa Carvalho Cavalcante de; Marques, Simone do Socorro Fernandes; http://lattes.cnpq.br/0651248478895645; Campos, Jamilie Suelen dos Prazeres; http://lattes.cnpq.br/4508719756740232; Moura, Carla Acatauassú Ferreira de; http://lattes.cnpq.br/4504006993667915
This study has the goal to make a bibliographic review about the efficacy of the carbohydrate counting upon the metabolic and glycemic control, elaborate an educational booklet to facilitate and to make flexible the food choices of the diabetic patients, to assist in the disease control and avoid complications. It is an integrated review of the specialized literature with qualitative approach that has been made through indexed articles search at Virtual Health Library with the support of The National Center for Biotechnology Information (Pub Med). The inclusion criteria were the integral gratuitous database since 2017 to 2021. The exclusion criteria were incomplete articles, divergent and ones did not reply the guiding question. In the end, nine scientific articles were taken. The results showed effective metabolic control for who made the carbohydrate counting and improving of the glycemic control with freedom and food choices flexibilization. It is an effective strategy to allow glycemic control, safety and quality of life. The review allowed to accomplish an educative technology by means of a carbohydrate counting booklet to make easy the understanding about the diabetes and simplify food choices day by day. It was concluded that the carbohydrate counting is a proper tool since favors best food choices and a healthy life, for this purpose was made an educational booklet about the understanding of diabetes and healthy eating aiming at learning carbohydrate counting with food group tables.
Os efeitos terapêuticos da ozonioterapia ao portador de pé diabético: uma revisão integrativa da literatura
(Centro Universitário do Estado do Pará, 2019) Neves, Sthefany Borges das; Araújo, Wellen Simone de Barros; Bittencourt, Margarete Carréra; http://lattes.cnpq.br/6459146408488843; Sozinho, Maria de Belém Ramos; http://lattes.cnpq.br/0704907714026557; Cruz, Maria de Nazaré da Silva; http://lattes.cnpq.br/5419032892855863
The term diabetes mellitus (DM) refers to a metabolic disorder of heterogeneous etiologies, characterized by hyperglycemia and metabolic disorders of carbohydrates, proteins and fats, resulting from defects in insulin secretion and / or action (Ministry of Health , 2013). Diabetic lesions tend to heal slowly and are often associated with difficult-to-resolve infections that are characterized in the presence of foot lesions due to neuropathies known as diabetic foot (CARDOSO et al., 2010). Ozone therapy is presented in the literature as an option for the treatment of lesions, both for its antimicrobial potential and for the ability to interfere with tissue repair in which it stimulates the formation of new vessels in the affected region, accelerating the formation of granulation tissue and decreasing healing time (CARDOSO et al., 2010). The most common complication among DM patients is diabetic foot, leading to several consequences such as hospitalizations and amputations of lower limbs. Approximately 15% of diabetics will develop ulcers, of which 15 to 20% will require some type of amputation. This is because the feet are vulnerable parts to the diabetic complications, since they are exposed daily to repetitive traumas. To seek scientific evidence on the benefits of the therapeutic use of ozone in diabetic lesions through an integrative literature review. The study is an integrative review of descriptive and exploratory literature in the national and international context. The research included original articles, review articles and master's thesis. To guide the present integrative review, the following question was asked: what are the scientific evidences about the therapeutic effects of ozone therapy to diabetic foot wearers from January 2010 to February 2019? In the initial search in the literature 20 articles were found according to the descriptors in the health sciences, after the analysis of the same 10 articles were selected that met the inclusion criteria of this study. The sample of this Integrative Review of Literature totaled 10 articles, of which 3 (30%) were found only in the MEDLINE database, 1 (10%) only in LILACS, 2 (20%) only in the VHL, 3 (30%) in the VHL and LILACS and 1 (10%) in the VHL and MEDLINE. According to the research carried out in the literature, all the studies showed benefits, such as: reduction of bacterial growth (NE1), reduction of amputation (NE2), decreased infection and reduced amputation (NE3 ), there was neovascularization and acceleration in tissue repair (NE3, NE6) and there was reduction of the lesion area. According to the studies conducted by IZADI, et al. (2019), it was found that the healing time depends on the size of the lesion and subsequent ozone dosage, the greater the lesion the longer the cicatrization time and the greater the dosage. The use of ozone in diabetic lesions is a practice that has satisfactory results, and the nurse must be up to date, conducting studies regarding the technique in order to provide a better treatment option and quality of life for diabetic foot patients.
Fatores de risco no desenvolvimento de diabetes gestacional
(Centro Universitário do Estado do Pará, 2022) Souza, Isabelle Cardoso de; Ozela, Cilea Maria dos Santos; Marques, Simone do Socorro Fernandes; http://lattes.cnpq.br/0651248478895645; http://lattes.cnpq.br/3869556585803094; Figueiredo, Sandra Maria dos Santos; http://lattes.cnpq.br/8530470051297070; Gaspar, Daniela Pinheiro; http://lattes.cnpq.br/9245835771527449
Diabetes Mellitus (DM) is defined as a disease resulting from endocrine-metabolic abnormality, which is classified as an absolute deficiency of the hormone insulin or resistance to its action that triggers high levels of serum glucose, which leads to interference entry of glucose into the cell, increasing the plasmatic concentration. Being characterized by being a common metabolic problem during pregnancy, with a prevalence of 3 to 25% of pregnancies, becoming defined as an intolerance to carbohydrates, in various degrees. To identify the risk factors that influence the development of gestational diabetes. This work can be defined as a systematic literature review. For the execution of the work, original scientific articles were searched on gestational diabetes mellitus, high-risk pregnancy, glycemic control and risks of gestational diabetes. Carrying out the analysis of the studies, it is possible to say that the risk factors in the development of gestational diabetes mellitus are caused by several reasons, among them the analyzed studies verified that the majority of the women who presented gestational diabetes mellitus during their pregnancy, presented factors risk factors such as overweight/obesity both pre-pregnancy and during pregnancy, in addition to maternal age (over 30 years), number of pregnancies, family history (1st-degree relatives) and history of gestational diabetes in another pregnancy. The present work, through the scientific bias, finds that several factors contribute to the risk of gestational diabetes mellitus, among them are overweight, obesity, maternal age, excess weight gain during pregnancy, number of pregnancies and deliveries, family history and history of another pregnancy.
Influência da gameterapia na intensidade da dor e seus impactos na qualidade de vida e equilíbrio em pacientes com neuropatia diabética
(Centro Universitário do Estado do Pará, 2021) Lima, Allan Mateus da Silva; Alfaia, Diego Mansur; Serra, Ana Clara Lima; Oliveira, Emanuelle Mayane do Nascimento; Paes, Lívia Moreira; Rocha, Larissa Salgado de Oliveira; Araújo, Matheus Sodré de
To evaluate the influence of gametherapy on pain intensity, balance and quality of life in patients with diabetic neuropathy. Methods: 4 volunteers, with a diagnosis of diabetic neuropathy aged 60.5 ± 7.50 years, underwent treatment with gametherapy for 24 sessions, 3x/week for 50 minutes and evaluated pre and post intervention by the questionnaire for pain screening. neuropathic pain (DN4) and numerical pain scale, Tinetti scale, Romberg test, Timed Up and Go (TUG), and quality of life by Neuropathy-Specific Quality of Life (NeuroQol). Higher mean values were observed after treatment for the Romberg OA and OF test (p<0.001 and p=0.016), respectively, Tinetti balance scale (p=0.003) and quality of life (p<0.001) when compared pre-treatment, as well as lower values for pain by NDT (p=0.007) and for TUG (p=0.007). In the present study, gametherapy proved to be effective in improving the symptoms of diabetic neuropathy, regarding pain and balance, thus contributing to improve the quality of life of these patients, since it acts directly on functional, physical and psychological issues.
O impacto da pandemia da COVID-19 no perfil clínico dos pacientes diabéticos atendidos no Centro de Especialidades Médicas do Cesupa no ambulatório de hiperdia durante o período de 2019 a 2021
(Centro Universitário do Estado do Pará, 2022) Covre, Paula Mendonça; Cavaléro, Talyssa Melo de Sousa; Bastos, Fabíola de Arruda; http://lattes.cnpq.br/9386935778704228
Diabetes Mellitus type 2 is a chronic disease resulting from a state of hyperglycemia and peripheral insulin resistance, which gained notoriety during the COVID-19 pandemic because it is a comorbidity of risk for the development of this infection, as well as other chronic diseases. Consequently, the control of glycemic levels of diabetic patients faced obstacles embedded by the chaotic scenario that developed in the pandemic period, such as: social isolation, decreased supply of basic health services, difficulty in accessing consultations and elective procedures. Therefore, it is important to conduct a study that analyzes the change in the clinical profile of diabetic patients during the pandemic period. To leverage data that translates the change in the clinical profile of diabetic patients followed at the Hiperdia outpatient clinic of the Center for Medical Specialties of CESUPA (CEMEC) in the period of 2019 to 2021. This is a descriptive cross-sectional analytical study conducted by collecting data from medical records provided by the Center for Medical Specialties of CESUPA (CEMEC). Regarding the epidemiological profile, the majority are female (63.9%) aged 60 to 89 years (57.4%). Regarding the anthropometric variables analyzed, weight and BMI, no significant changes were found, both in BMI (p=0.124), or weight (p=0.244), between 2019 and 2020; between 2020 and 2021, there were also not many changes. In the present study, when comparing the number of drugs between 2019 and 2020, there was an increase (Mean ± SD:1.5 ± 0.7 vs 1.7 ± 0.8; P=0.050). Regarding the number of tablets, there was also an increase between 2019 and 2020 (Mean ± SD: 3.5 ± 1.7 vs 3.9 ± 1.7; P<0.001). Between 2020 and 2021, the number of medicines did not differ significantly (p=0.881) nor the number of tablets (p=0.814). It was possible to observe that the daily dose of metformin between 2019 and 2020 showed an increase (Mean ± SD: 1607.5 mg ± 686.5 mg vs 1761.3 mg ± 673.8 mg; P=0.019). Regarding laboratory tests, between 2019 and 2020 there was low difference between fasting blood glucose values (Mean ± SD: 134.4 ± 37.4 vs 144.2 ± 59.3; P=0.348), postprandial glycemia (Mean ± SD: 177.0 ± 76.7 vs 154.8 ± 40.3; P=0.384) and glycated hemoglobin (Mean ± SD: 7.0 ± 1.3 vs 6.9 ± 2.4; P=0.315). Before these results, it is possible to conclude that during the pandemic there was an adjustment in the therapeutic plan of the followed-up patients, with an increase in the number of medications and tablets. In addition, most patients improved glycemic levels by fasting glycemia, postprandial glycemia and glycated hemoglobin. Thus, it is ensured that this work is of great value, because it is found that despite the obstacles faced by patients during the pandemic, diabetes control was achieved.
Perfil clínico epidemiológico de pacientes cadastrados no Hiperdia – PA: série histórica de 10 anos
(Centro Universitário do Estado do Pará, 2021) Monteiro, Fernanda Tereza Silva; Silva, Rafaela Abadessa da; Neves, José Joaquim de Oliveira; http://lattes.cnpq.br/9075377277147026
Introduction: Brazil has a high prevalence of people with Diabetes Mellitus and Systemic Arterial Hypertension, with significant growth in recent years, with well-known risk factors, in addition to serious complications, therefore deserving appropriate interventions. Objectives: To characterize the clinical and epidemiological profile of patients enrolled in the Hiperdia program in the State of Pará from 2003 to 2012. Methodology: The Study is a 10-year (2003 to 2012) historical series of a descriptive and quantitative type, with a survey of the number of cases of patients with concomitant hypertension and DM, using data available from the public domain by DATASUS. The data are detailed by the municipalities of the State of Pará, more specifically by their regional situations (Araguaia, Baixo Amazonas, Carajás, Lake Tucuruí, Metropolitana I, II and III Caetés, Tapajós, Tocantins, Xingu and Marajó I and II). Results: The study shows that about 65% of the registered patients were female and the age group where there was the highest record was 55 to 59 years old. About 77% of the patients registered in the program were not smokers, 57% were not sedentary and 58% were not overweight. It was found that 93% of the participants did not have AMI, 95% of the patients did not have coronary heart disease, 12% had a stroke and 90% of those registered did not have kidney disease. Approximately 5% of the patients had a diabetic foot condition and the elderly, 3% had to undergo amputation.36% of the patients registered in the program were part of the Metropolitan Health Region I. Conclusion: Among those registered, 65% were female; The predominant age group was 55 to 59 years old; 57% practice physical activity and 23% were smokers; 58% were overweight; absence of AMI in 93% and coronary disease in 95%; stroke observed in 12% of cases and foot diabetic in 5% (since 3 years, have needed amputation), renal complications in 10% of cases and the regional health that registered the most was Metropolitano I.
Perfil epidemiológico de internações por Diabetes Mellitus no Brasil de 2015 a 2019
(Centro Universitário do Estado do Pará, 2020) Cruz, Alfredo Henrique de Oliveira; Eguchi, Bruna Sayuri; Rodrigues, Cybelle Cristina Pereira; http://lattes.cnpq.br/9540610661271303
Introduction: Diabetes Mellitus (DM) is a chronic metabolic disorder, which causes a state of persistent hyperglycemia, and can be classified according to the etiology into type 1 (DM1), type 2 (DM2), gestational, among other specificities. Its main symptoms weight loss, polyuria, polyphagia and polydipsia, which can appear silently years before diagnosis. The increase in the prevalence of DM is associated with several factors, mainly the epidemiological transition, with the increase in life expectancy in Brazil and the consequent aging of the population. Objective: Analyze the profile of hospitalizations for Diabetes Mellitus in Brazil, in the period from 2015 to 2019. Methodology: Epidemiological, ecological, quantitative and descriptive study, based on secondary data related to hospital admissions for Diabetes Mellitus available at SIH / DATASUS. All hospitalization records that contained ICD E00 to E90 as the main diagnosis were included. The variables were grouped into the number of hospitalizations for DM in each Brazilian region; socio-demographic profile (age, sex, race / color); character of assistance; number of deaths; mortality rate; average value per hospitalization; hospitalization time. Results: In the period from 2015 to 2019, there were 58,005,782 hospitalizations, of which 1,230,786 were due to endocrine and metabolic diseases, which corresponds to 2.12% of the total hospitalizations. Out of the hospitalizations for endocrine and metabolic diseases, more than 50% are diagnosed with DM. The highest number of hospitalizations is in the Northeast (1.39%). The age group of 60 to 64 and 65 to 69 (both with 12.2% each), female (51.7%), race / brown color (36.7%) and emergency care (94.7% ) were more prevalent. A variation in the hospital mortality rate was analyzed in the different regions, with a greater increase in the North (0.54) and a greater decrease in the Northeast (0.69). There was an increase in the average values per hospitalization throughout Brazil, with a total expenditure of R $ 4,590.80 in 2019. As for the length of stay per hospitalization, there was a higher average in 2018 (8.1 days). Conclusion: The present study showed a decrease in the percentage of hospitalizations for diabetes mellitus in Brazil over the analyzed years, which reflects the effectiveness of public health policies implemented in relation to the prevention and diagnosis of diabetes mellitus.
Relação entre estado nutricional e qualidade de vida de pacientes idosos diabéticos acompanhados em uma clínica escola
(Centro Universitário do Estado do Pará, 2022) Ferreira, Ana Beatriz da Silva; Nestor, Gabrielli Karolina Monteiro; Campos, Jamilie Suelen dos Prazeres; http://lattes.cnpq.br/4508719756740232; Marques, Simone do Socorro Fernandes; http://lattes.cnpq.br/0651248478895645; Moura, Carla Acatauassú Ferreira de; http://lattes.cnpq.br/4504006993667915
Aging is something common for all individuals, consequently chronic non-communicable diseases may arise, such as Diabetes Mellitus. It is known that the diagnosis of diabetes can impact the quality of life due to changes in the routine that the elderly have. This study aims to relate the nutritional status with the perception of quality of life of elderly patients diagnosed with diabetes mellitus. This is a cross-sectional quantitative study carried out with 41 elderly people in a teaching clinic. Four instruments were used for data collection: a socioeconomic questionnaire, a data collection protocol and the B-PAID and WHOQOL-BREF scales to assess quality of life. Data analysis was performed using descriptive statistics using mean and standard deviation. Most of the elderly analyzed are aged between 60 and 69 years (63.4%), are female (53.7%), married (48.8%), studied up to elementary school (65.9%) and have an income of up to 1 minimum wage (51.2%). Regarding nutritional status, most are overweight (61%). In assessing quality of life using the B-PAID, the largest dimensions observed were food and emotional. In the WHOQOL-BREF, the major domains were psychological and personal relationships. There was no significant association between the perception of quality of life and the nutritional status of elderly people with diabetes, noting that most of the elderly diabetic participants have a good quality of life, even living with diabetes.